Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
24 Ergebnisse
| LX7HSP | Sarepta Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Sarepta Therapeutics Inc. | 10,438 | 10,438 | 2,346 | 29,570 % | - | Lang & Schwarz | ||
| LX7HSQ | Sarepta Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Sarepta Therapeutics Inc. | 12,525 | 12,525 | 3,474 | 15,484 % | - | Lang & Schwarz | ||
| LX7N9R | Sarepta Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Sarepta Therapeutics Inc. | 11,472 | 11,472 | 2,873 | 22,590 % | - | Lang & Schwarz | ||
| LX9G04 | Sarepta Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Sarepta Therapeutics Inc. | 13,533 | 13,533 | 4,394 | 8,686 % | - | Lang & Schwarz | ||
| MG34RC |  | Sarepta Therapeutics Inc./Faktor/Short [2]/MS | - | - | put | Sarepta Therapeutics Inc. | 25,244 | 25,244 | - | 49,907 % | - | Morgan Stanley | |
| MK4C09 | | Sarepta Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Sarepta Therapeutics Inc. | 8,417 | 8,417 | - | 50,018 % | - | Morgan Stanley | |
| MK9P2N | | Sarepta Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Sarepta Therapeutics Inc. | 8,417 | 8,417 | - | 50,018 % | - | Morgan Stanley | |
| MM1ZMM | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 12,988 | 12,988 | 3,813 | 22,875 % | - | Morgan Stanley | |
| MM6X8H | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 6,787 | 8,490 | 1,652 | 49,584 % | - | Morgan Stanley | |
| MM6X8J | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 10,180 | 12,730 | 2,395 | 24,406 % | - | Morgan Stanley | |
| MN068X | | Sarepta Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Sarepta Therapeutics Inc. | 11,223 | 11,223 | - | 33,358 % | - | Morgan Stanley | |
| MN10NY | | Sarepta Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Sarepta Therapeutics Inc. | 12,625 | 12,625 | - | 25,028 % | - | Morgan Stanley | |
| MN10NZ | | Sarepta Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Sarepta Therapeutics Inc. | 13,467 | 13,467 | - | 20,030 % | - | Morgan Stanley | |
| MN123Y | | Sarepta Therapeutics Inc./Faktor/Short [4]/MS | - | - | put | Sarepta Therapeutics Inc. | 21,037 | 21,037 | - | 24,923 % | - | Morgan Stanley | |
| MN123Z | | Sarepta Therapeutics Inc./Faktor/Short [5]/MS | - | - | put | Sarepta Therapeutics Inc. | 20,196 | 20,196 | - | 19,926 % | - | Morgan Stanley | |
| MN624J | | Sarepta Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Sarepta Therapeutics Inc. | 13,467 | 13,467 | - | 20,030 % | - | Morgan Stanley | |
| MN88T9 | | Sarepta Therapeutics Inc./Faktor/Short [3]/MS | - | - | put | Sarepta Therapeutics Inc. | 22,439 | 22,439 | - | 33,251 % | - | Morgan Stanley | |
| MN9LJ1 | | Sarepta Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Sarepta Therapeutics Inc. | 12,625 | 12,625 | - | 25,028 % | - | Morgan Stanley | |
| MN9XXV | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 12,169 | 12,169 | 3,238 | 27,739 % | - | Morgan Stanley | |
| MN9XXW | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 14,197 | 14,197 | 4,704 | 15,696 % | - | Morgan Stanley | |
| MR153C | | Sarepta Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Sarepta Therapeutics Inc. | 11,223 | 11,223 | - | 33,358 % | - | Morgan Stanley | |
| MR1GG9 | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 11,304 | 14,140 | 2,972 | 16,033 % | - | Morgan Stanley | |
| MR2E5P | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 15,092 | 15,092 | - | 10,382 % | - | Morgan Stanley | |
| MR3G58 | | Sarepta Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Sarepta Therapeutics Inc. | 12,837 | 16,050 | 4,019 | 4,691 % | - | Morgan Stanley |